If you have ever felt pain during intimacy, or because of intimacy, or in anticipation of it, and been told it’s “normal,” been told to drink a glass of wine to relax, been dismissed, misdiagnosed, or sent home without answers, this post is for you.
Pelvic pain is one of the most prevalent and most undertreated conditions affecting intimate wellbeing across all genders. In the United States alone, research reports that 1 in 7 people with uteruses are affected by chronic pelvic pain (and that’s only what gets reported and diagnosed). The actual number is almost certainly higher. Research has also found that more than one-third of non-binary people, transgender men, and gender-diverse individuals assigned female at birth experience chronic widespread pain, a rate higher than in cisgender populations. And people with penises are far from exempt: over 70% of men with interstitial cystitis report sexual dysfunction, and chronic prostatitis/chronic pelvic pain syndrome is one of the most common urological diagnoses in people under 50.
Pelvic pain doesn’t just affect sex, it affects how you feel in your body, your relationships, and your sense of self as an intimate being. It can create cycles of avoidance, grief, shame, and relational strain that compound the physical experience in ways that are devastating.
This post is a comprehensive, evidence-based guide to the major pelvic pain conditions that affect sexual wellbeing. We’ll be discussing what they are, why they create the effects they do, and what the research says about treatment.
Important note: I am a certified sexuality educator and sex and relationship practitioner, not a physician. Everything here is educational information, not medical advice. Please work with qualified healthcare providers for diagnosis and treatment. What I hope this post gives you is the language, knowledge, and sense of legitimacy to advocate for yourself in those conversations.
The pelvis houses a complex network of organs, muscles, nerves, blood vessels, and connective tissue. When any of these systems are in distress, through inflammation, nerve sensitization, muscle dysfunction, structural abnormality, or central sensitization, pain can result. That pain may be constant or intermittent, localized or diffuse, sharp or burning or aching, and can be triggered or worsened by sexual activity, specific positions, arousal, orgasm, bowel movements, urination, menstruation, or simply existing.
Chronic pelvic pain is defined as continuous or episodic pain in the lower abdomen or pelvis lasting more than six months. It is frequently associated with conditions including irritable bowel syndrome, anxiety, depression, fibromyalgia, and other chronic pain conditions. Central sensitization, a state in which the nervous system becomes amplified and hypersensitive to pain signals, is a documented mechanism in many pelvic pain conditions and helps explain why pain can persist, spread, and intensify over time even when local tissue damage is minimal.
Understanding pelvic pain through this lens is important for several reasons. It validates the reality and severity of people’s experiences, it explains why pelvic pain conditions so frequently overlap and co-occur, and it points toward why treatment almost always needs to be multimodal: addressing the nervous system, the musculoskeletal system, the psychological dimension, and the relational context together.
Endometriosis is a condition in which tissue similar to the endometrium (the lining of the uterus) grows outside the uterus, on the ovaries, fallopian tubes, bowel, bladder, and in some cases beyond the pelvis. This tissue responds to hormonal cycles and bleeds where it implants, causing inflammation, scarring, adhesions, and cysts. A 2023 NIH-published review in Med describes endometriosis as “a heterogeneous disease where neurogenic sensitization can lead to chronic pain within and beyond the pelvis.”
Endometriosis affects an estimated 1 in 10 people with uteruses, yet the average time from symptom onset to diagnosis is 7 to 10 years. This delay causes profound harm and reflects gendered patterns of dismissal in medicine, the normalization of severe pain in people with uteruses, and systemic research underfunding.
Endometriosis affects sexual wellbeing through multiple simultaneous pathways. Deep dyspareunia, pain during penetrative sex, particularly with deep contact near the cervix, is one of the most common and distressing symptoms. Research indicates that approximately 40% of people with endometriosis-related chronic pelvic pain also experience sexual symptoms, including vaginismus.
Beyond the direct physical pain, endometriosis disrupts sexual wellbeing through the anticipation of pain, which creates avoidance, anxiety before intimacy, and an involuntary protective bracing response that can itself cause pain and muscle dysfunction. It affects desire, because living with chronic pain is exhausting and consuming, and because the nervous system learns to associate intimacy with threat. It affects body image and the sense of inhabiting one’s own body as a site of pleasure rather than suffering. And it profoundly affects relationships, particularly when partners don’t understand why intimacy is difficult, or when years of painful sex have created distance and grief that never got to be talked openly about.
Hormonal treatments used to manage endometriosis can themselves affect lubrication, desire, and tissue health, adding complexity to this already layered picture.
Treatment for endometriosis requires a multidisciplinary approach and more research is required for expanded treatment options. Surgical excision of endometriosis lesions is considered the gold standard for addressing the structural cause, and can significantly reduce pain and other symptoms, including sexual pain. Hormonal management (including hormonal IUDs, combined contraceptives, and GnRH agonist/antagonist medications) can suppress lesion activity and reduce cyclical pain.
Pelvic floor physical therapy can be a critical component of care for endometriosis-related sexual pain, addressing the muscular guarding, hypertonic pelvic floor, and scar tissue that develop alongside the underlying disease. Pain management approaches, including nerve blocks, low-dose naltrexone, and, in some cases, medical cannabis, are areas of growing research.
Vulvodynia is chronic vulvar (external genitalia) pain lasting three months or more without an identifiable cause. It is a diagnosis of exlusion, meaning doctors only diagnose it after ruling out other causes such as infections or skin disease. It affects an estimated 6–28% of people with vulvas across their lifetime, making it extraordinarily common, yet few of those who experience it seek medical help, and of those who do, many face repeated misdiagnosis, dismissal, or ineffective treatment.
Vestibulodynia (formerly called vulvar vestibulitis syndrome) is a subtype of vulvodynia specifically localized to the vestibule, the tissue surrounding the vaginal opening. Provoked vestibulodynia (PVD), in which pain is triggered by touch or pressure to the vestibular tissue, is the most common form and the most directly relevant to sexual activity.
The origins of vulvodynia is multifactorial and incompletely understood. Contributing factors may include: peripheral nerve sensitization, central sensitization, pelvic floor hypertonicity, hormonal influences, inflammatory factors, and overlapping chronic pain conditions. Vulvodynia commonly co-occurs with fibromyalgia, irritable bowel syndrome, interstitial cystitis, endometriosis, depression, and anxiety.
Vulvodynia creates a specific and particularly cruel dynamic in intimate life: any touch to the vulva, ncluding the most gentle, loving touch, can feel like burning, stinging, tearing, or knife-like pain. People with vulvodynia describe cotton ball contact feeling “like the scraping of a knife.” This means that what is supposed to be pleasurable is registered by the nervous system as threatening.
The consequences for sexual wellbeing are pervasive. Penetration, or attempted penetration, typically causes severe pain. Arousal itself can increase sensitivity and discomfort. Clothing and sitting can be painful. The chronic experience of pain in tissue associated with pleasure and intimacy can create profound disconnection from one’s body as a site of safety, pleasure, or joy.
Vulvodynia is associated with significantly lower sexual satisfaction, higher rates of sexual avoidance, relationship distress, and reduced quality of life for both the person with the condition and their partners. The psychological burden of a condition that makes intimacy painful causes high rates of depression and anxiety.
For people who are neurodivergent, already managing sensory sensitivities, the added layer of painful genital touch can interact with existing sensory processing patterns causing added complexity.
Pelvic floor physical therapy has robust evidence for vulvodynia and vestibulodynia. A review confirmed that pelvic floor physical therapy has robust evidence-based support and clear benefit as a first-line treatment for pelvic floor disorders including dyspareunia and vulvodynia. Treatment includes manual therapy, myofascial release, biofeedback, and graded desensitization of the vestibular tissue.
Topical treatments including compounded topical lidocaine (applied before sexual activity), low-dose topical estrogen or testosterone, and cromolyn sodium. Oral medications including tricyclic antidepressants (amitriptyline, nortriptyline) and gabapentinoids have been used, with mixed evidence. Botox injections into vestibular and pelvic floor tissue have shown promising results in treatment-resistant cases, with improvements in pain scores and sexual function documented in multiple studies.
Vestibulectomy, surgical removal of the vestibular tissue, is reserved for conditions not responding to conservative management and has demonstrated significant improvement in pain and sexual function in appropriately selected patients.
Psychological approaches including CBT and pain education can be helpful adjuncts for some. They address pain catastrophizing, hypervigilance, and the nervous system’s learned threat response. Sex therapy, coaching, and education can be very valuable as well.
Vaginismus / Sexual Pain-Penetration Disorder / Genito-Pelvic Pain/Penetration Disorder is the involuntary spasming or tightening of the pelvic floor muscles that prevents or makes vaginal penetration difficult or impossible. Clinicians are increasingly using the DSM-5 term Genito-Pelvic Pain/Penetration Disorder (GPPPD), which encompasses both dyspareunia and vaginismus, reflecting growing evidence that these conditions exist on a continuum rather than as categorically distinct entities.
Vaginismus/GPPPD exists on a spectrum from difficulty with some forms of penetration (inserting a tampon, a speculum) to complete inability to tolerate any vaginal entry. It can be primary (present from the first attempt at penetration) or secondary (developing after a period of pain-free function, often following trauma, infection, birth, or another triggering event).
The origins are complex and almost never purely psychological, despite decades of medical framing that pathologized it as such. Contributing factors include: pelvic floor hypertonicity, nerve sensitization (including from co-occurring conditions like vulvodynia or endometriosis), trauma history, learned pain-avoidance responses, hormonal factors, and the protective function of a nervous system that has learned that penetration = pain.
For people with GPPPD/vaginismus, the impact on sexual wellbeing can devastating. Penetration, or any attempt at it, may be impossible or excruciatingly painful. This affects not only sexual intercourse but gynecological care (pelvic exams, IUD insertion), tampon use, and any other form of vaginal entry. The anticipatory anxiety surrounding penetration often becomes as limiting as the physical response itself, creating a cycle that is difficult to interrupt.
The relational impact can be significant: partners may feel rejected, confused, or helpless. The person with GPPPD/vaginismus often carries profound shame and a sense of being “broken” or “not enough,” particularly in a culture that treats penetrative intercourse as the default, expected, top-tier form of sexual expression.
It is worth noting that GPPPD/vaginismus does not mean a person cannot experience pleasure, desire, arousal, or fulfilling intimacy. It means that specific forms of physical entry are currently inaccessible or painful. Expanding the understanding of what intimacy includes, and finding what the body can enjoy, can be part of the healing.
Pelvic floor physical therapy is the primary evidence-based treatment: working to reduce muscle tone, desensitize the pelvic floor and vestibular tissue, and gradually restore the nervous system’s sense of safety around penetration. This typically includes manual therapy, biofeedback, and graded use of vaginal dilators as part of a progressive desensitization program, always at the patient’s own pace and with full control.
Psychological support, including CBT, mindfulness-based approaches, and trauma-informed care, addresses the anxiety, fear response, and hypervigilance that maintain the condition. For those with trauma histories, trauma-specific treatment (EMDR, somatic experiencing) may be important components of care.
Sex therapy, education, and coaching that explicitly addresses GPPPD/vaginismus, including working with partners, reframing what intimacy includes, and rebuilding a relationship with the body as a site of safety and pleasure, are underutilized and powerful.
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition characterized by bladder or pelvic pressure, pain, and urinary symptoms (urgency, frequency, nocturia) without infection or other identifiable cause. The American Urological Association defines it as symptoms lasting more than six weeks without another explanation. It is also frequently misdiagnosed as recurrent UTIs, particularly in people who present with post-coital urinary symptoms.
IC/BPS is closely linked to other chronic pelvic pain conditions. Research has shown that 86% of people with chronic pelvic pain have IC, and studies confirm a significant association between IC/BPS and endometriosis, with researchers describing them as “evil twins syndrome” in some literature.
IC/BPS has a profound and pervasive impact on sexual wellbeing. Research confirms that sexual dysfunction and low sexual self-efficacy are common in patients with IC/BPS. The mechanisms are multiple: pain during or after penetration (particularly from bladder compression during deep penetration), urgency to urinate during or immediately after sexual activity, pelvic floor hypertonicity that co-occurs with IC/BPS and affects comfort and function, the fatigue and emotional burden of managing a chronic condition, and the hypervigilance that develops when sex reliably triggers symptom flares. Around 75% of people with IC/BPS report exacerbation of symptoms following sexual intercourse, a pattern that understandably creates avoidance, anticipatory anxiety, and relational strain.
The experience of needing to urinate urgently during or immediately after intimacy, which many people have been taught to attribute to UTIs, can be disruptive and embarrassing, and often goes unrecognized as an IC/BPS symptom for years.
IC/BPS treatment is multimodal. First-line conservative approaches include dietary modification (identifying and avoiding trigger foods and beverages), stress management (because IC symptoms are strongly stress-responsive), bladder training, and pelvic floor physical therapy.
Second-line treatments include oral medications (pentosan polysulfate sodium, antihistamines, low-dose tricyclic antidepressants, gabapentin) and neuromodulation approaches including sacral nerve stimulation. 2025 guidelines on male chronic pelvic pain also highlighted emerging evidence for low-intensity shockwave therapy and acupuncture.
Identifying IC/BPS-specific triggers for sexual symptoms, including positions that put less pressure on the bladder during penetration, timing of sexual activity relative to bladder fullness, urinating before (but not too immediately before) sex. can meaningfully improve sexual experience. Working with a practitioner who understands IC/BPS in the context of intimacy can also be valuable.
Pudendal neuralgia is chronic pain in the distribution of the pudendal nerve, which serves the perineum, genitals, rectum, and bladder. It is caused by compression, entrapment, or irritation of the pudendal nerve. Pudendal neuralgia is one of the more underdiagnosed pelvic pain conditions, in part because its symptom distribution is unusual and in part because clinical familiarity with it remains limited.
The pain of pudendal neuralgia is typically described as burning, stabbing, or electric shock-like, and is characteristically worse when sitting and improved when standing or lying down. It can affect one or both sides of the perineum. Causes include prolonged sitting (cycling is a well-documented precipitant), childbirth, pelvic surgery, trauma, and entrapment from pelvic floor hypertonicity.
Because the pudendal nerve supplies the clitoris, penis, labia/scrotum, and perineal region, pudendal neuralgia has direct effects on sexual function and intimate experience. Sexual activity, which involves increased blood flow, engorgement, and nerve activation in the pudendal distribution, can trigger or significantly worsen pudendal neuralgia pain. Arousal itself may be painful. Orgasm, which involves intense pudendal nerve activation, may be excruciating or may trigger post-orgasmic pain flares lasting hours to days. Many people with pudendal neuralgia describe essentially losing the ability to experience pleasurable genital sensation.
Pudendal neuralgia is also a primary driver of Persistent Genital Arousal Disorder/Genitopelvic Dysesthesia (PGAD/GPD), discussed below, where misfiring of the pudendal nerve creates unwanted, intrusive sensations of arousal.
Evidence-based treatment for pudendal neuralgia includes pelvic floor physical therapy (addressing muscle tension that may be contributing to nerve compression), pudendal nerve blocks (injections of local anesthetic and corticosteroid to reduce nerve inflammation), neuromodulation approaches including sacral nerve stimulation, and surgical decompression/neurolysis for confirmed nerve entrapment that has not responded to conservative management. Oral medications including tricyclic antidepressants, gabapentinoids, and SNRIs are used for neuropathic pain management.
Early identification and treatment significantly improve outcomes. Anyone with perineal burning pain that is worse when sitting and better when standing, that involves the genital or rectal area, and that is associated with sexual pain or dysfunction, should request evaluation for pudendal neuralgia specifically as it is commonly missed at initial presentation.
Persistent Genital Arousal Disorder/Genitopelvic Dysesthesia (PGAD/GPD) is one of the most distressing, least understood, and most stigmatized pelvic pain conditions. It is characterized by unrelenting, unwanted, persistent, intrusive, and spontaneous sensations of genital arousal, pressure, tingling, throbbing, pulsing, that are not connected to sexual desire and are not relieved by orgasm, or only temporarily so.
Research documents that PGAD/GPD is associated with “a significant, negative psychosocial impact that may include emotional lability, catastrophization, and suicidal ideation.” This is a condition that destroys quality of life and is routinely dismissed or disbelieved by medical providers who have never heard of it.
PGAD/GPD has multiple possible causes like clitoral, vestibular, urethral, or bladder issues, pelvic floor dysfunction, pudendal neuralgia, pelvic congestion syndrome, Tarlov cysts, lumbar disc disease, certain medications, and neurological conditions.
PGAD/GPD creates a painful paradox in intimate life: the sensations associated with arousal and pleasure become constant, distressing, and unwanted. Intimacy can worsen symptoms or create conflicted experiences in which physical sensation and emotional experience are completely disconnected. Many people with PGAD/GPD avoid sexual activity entirely because of the risk of triggering worsened symptoms. Relationships suffer profoundly, both from the individual’s experience and from partners’ confusion and helplessness in the face of a condition they cannot understand.
The stigma of PGAD/GPD is particularly severe: people with this condition frequently report being disbelieved, told their symptoms are signs of underlying desire, or treated with condescension and ignorance by medical providers. The experience of having your distress sexualized, trivialized, or dismissed is a secondary trauma that compounds the primary condition.
Treatment is based on identifying the causative region and addressing it directly. A multidisciplinary team approach, medical provider, pelvic floor PT, and sex therapist/counselor/coach/educator, has been shown to be associated with patient-perceived benefits, satisfaction, and feelings of validation and normalcy, and improved sexual function.
Depending on etiology: pudendal nerve blocks and surgical neurolysis for pudendal involvement, interventional radiology embolization for pelvic congestion syndrome or arteriovenous malformations, pelvic floor physical therapy for pelvic floor dysfunction, Tarlov cyst management for spinal causes, and medication adjustment for pharmacologically-triggered cases. Pharmacological management may include anti-seizure medications, low-dose antidepressants, or other agents targeting neuropathic pain.
Pelvic congestion syndrome is caused by varicose veins in the pelvis, dilated, incompetent veins (particularly ovarian veins) that cause blood to pool in the pelvis, creating chronic, aching, heavy pelvic pain. It is most common in people who have had multiple pregnancies but can occur without them. It is frequently undiagnosed because the varicosities are internal and not visible, and because the pain often worsens with prolonged standing, sitting, and sexual activity, making it easy to attribute to other causes.
Pelvic congestion syndrome characteristically causes pain during and after sexual activity, particularly deep penetration, and post-coital aching that can last hours. The worsening of pelvic pressure and heaviness with arousal (which increases pelvic blood flow to already congested vessels) creates a direct mechanism for sexual pain and a strong incentive for avoidance. Many people with pelvic congestion syndrome develop significant anticipatory anxiety and sexual avoidance patterns before the underlying cause is identified.
Diagnosis requires imaging, typically transabdominal and/or transvaginal Doppler ultrasound, CT angiography, or pelvic venography. Once confirmed, interventional radiology treatment with ovarian vein embolization is the most effective treatment and has demonstrated significant improvement in pelvic pain and sexual function in multiple studies. Hormonal management (progestins) can reduce vascular tone and symptom severity. Pelvic floor physical therapy addresses the secondary muscle dysfunction that develops.
Uterine fibroids are noncancerous growths of the uterine muscle, present in up to 70–80% of people with uteruses by age 50. Adenomyosis is a condition in which endometrial-like tissue grows into the uterine wall, causing the uterus to enlarge and become tender. Both conditions are frequently dismissed as “normal” or minimized in medical encounters, particularly for Black women, who develop fibroids earlier, more frequently, and with greater severity, and who face well-documented disparities in diagnosis and treatment.
Large or strategically positioned fibroids can cause deep dyspareunia, pelvic pressure during sex, heavy and prolonged menstrual bleeding that affects intimate life, pelvic heaviness, and, in some positions, significant pain from compression. Adenomyosis causes severe periods and deep pelvic pain that can make intimacy around menstruation essentially impossible, and in some cases, causes pain throughout the cycle.
The body image effects of fibroids and adenomyosis, including a visibly distended abdomen from a significantly enlarged uterus, can affect how people inhabit their bodies.
Treatment options range from watchful waiting for asymptomatic cases, to hormonal management (GnRH agonist/antagonist medications to shrink fibroids, or hormonal suppression for adenomyosis), to minimally invasive uterine fibroid embolization, laparoscopic or robotic myomectomy (fibroid removal preserving the uterus), and hysterectomy for severe or treatment-refractory cases. For adenomyosis, hysterectomy is often the only definitive treatment, though hormonal management can significantly reduce symptoms.
Pelvic inflammatory disease is an infection of the upper reproductive tract, uterus, fallopian tubes, and ovaries, most often caused by sexually transmitted infections including chlamydia and gonorrhea. Untreated or inadequately treated PID can lead to tubal scarring, chronic pelvic pain, adhesions, and risk of ectopic pregnancy.
PID can cause acute pelvic pain that makes sexual activity acutely impossible during active infection. Its longer-term effect is through the chronic pelvic pain, adhesions, and tissue changes that can follow inadequately treated or recurrent infections. Pain during deep penetration from tubal involvement or uterine tenderness, reduced desire from chronic pain burden, and the emotional weight of a sexually-acquired infection that carries social stigma all affect intimate wellbeing. Research confirms the association between PID and interstitial cystitis, highlighting how one condition can cascade into others over time.
Prompt, complete antibiotic treatment of PID is essential. For those experiencing chronic pelvic pain following PID, the same approaches used for other chronic pelvic pain conditions apply: pelvic floor PT, pain management, and addressing the relational and intimate impacts with appropriate support.
Research found that more than one-third of non-binary people and transgender men experience chronic widespread pain. Transgender and gender-diverse people face significantly higher rates of chronic pain than their cisgender counterparts, alongside well-documented barriers to accessing affirming care, including providers who use incorrect anatomy language, who assume only cisgender women have pelvic pain, or who conflate gender-affirming care with pelvic pain treatment in ways that are unhelpful.
Testosterone therapy can cause vaginal atrophy in people with vaginas, which may contribute to pelvic floor changes, dryness, and pain. Research also found a complex relationship between testosterone use and chronic pelvic pain, with some transgender folks experiencing new-onset pelvic pain after testosterone initiation. This is an area requiring significantly more research.
Gender-affirming surgeries create new anatomies that have their own pelvic health considerations. Vaginoplasty, phalloplasty, metoidioplasty, and hysterectomy all have specific post-operative pelvic health implications, and pelvic floor PT plays an important role in post-surgical recovery and sexual function for all of these procedures.
Chronic prostatitis/chronic pelvic pain syndrome is one of the most common urological diagnoses in people with prostates under the age of 50. It is characterized by pelvic pain, perineal pain, and often urinary and ejaculatory symptoms.
CP/CPPS is associated with significant sexual dysfunction: ejaculatory pain, reduced erectile function, decreased libido, and pain during or after orgasm. The psychological burden of an unexplained chronic pain condition associated with ejaculation and sexual function is enormous, and it is rarely addressed in standard urological care. Pelvic floor physical therapy, trigger point release, and psychological support have emerging evidence in CP/CPPS. A 2025 Chronic Pelvic Pain Guideline also highlighted acupuncture as being a supportive treatment.
Across all pelvic pain conditions, several treatment principles and modalities are consistently supported by evidence and patient reports.
This is the single most broadly applicable, most evidence-supported intervention for pelvic pain conditions affecting sexual wellbeing. A review confirmed that pelvic floor physical therapy has “robust evidence-based support and clear benefit as first-line treatment” for pelvic floor disorders including myofascial pain, dyspareunia, vaginismus, and vulvodynia. A systematic review and meta-analysis confirmed significant results for pain and quality of life with physiotherapy interventions for female dyspareunia. A randomized controlled trial confirmed significant improvements in pelvic floor muscle function, sexual function, and pain following pelvic floor rehabilitation for dyspareunia.
What pelvic floor physical therapy includes: manual therapy and myofascial release (internal and external), biofeedback, progressive desensitization, neuromuscular re-education, and home exercise programs. Sessions are with a specialized pelvic floor physical therapist who has training beyond standard PT, and sessions involve a patient who has full control over what happens and at what pace.
Finding a pelvic floor PT who is LGBTQIA+ affirming, who uses correct anatomical language for your body, who is experienced with your specific condition, and who understands the sexual wellbeing dimension is worth the search, too.
Pain is processed in the brain. The nervous system learns, and unlearns, threat responses. This is not to say pelvic pain is psychological in origin, but that psychological approaches can be powerful components of treatment alongside physical ones.
CBT-based pain programs have evidence for chronic pelvic pain. Mindfulness-based approaches for pain management have a growing evidence base, too. Trauma-informed care is essential for anyone whose pelvic pain is entangled with a history of sexual trauma, medical trauma, or abuse. Research explicitly notes that neglecting trauma in pelvic pain treatment contributes to poor outcomes and dropout. Duh!
Sex therapy and sex coaching specifically address the intimate, relational, and identity dimensions of living with pelvic pain, rebuilding a relationship with one’s body as capable of pleasure, working through grief about what intimacy has become, communicating with partners, and exploring what forms of connection and pleasure remain accessible.
When penetrative sex is painful or impossible, intimacy, connection, closeness, and pleasure has not ended. What is required is a genuine willingness to expand the definition of intimacy beyond the narrow script that most of us were handed, one in which penetration is assumed to be the main event and everything else is secondary.
There are expansive possibilities for pleasure, closeness, and erotic connection that do not require penetration, contact with painful areas, and the same energy or physical capacity that chronic pain may have reduced. Finding them requires information, permission, and sometimes support, all of which are available. Here’s two resources to get started: (free) Yes! No. Maybe? list and Everything But: The Redefining Intimacy Menu.
Pelvic pain conditions can be relational experiences. Partners are affected, too. The research is consistent: untreated relational strain around pelvic pain worsens outcomes. Honest, supported communication between partners about what’s happening, what it means, what each person needs, and how to stay connected is part of treatment, too.
Ready for support navigating this?
Book a session with Byrd: individual and relationship sessions for people navigating challenges like these.
Download the free Yes! No. Maybe? Checklist: a starting point for exploring what intimacy can include for your body.
Explore Everything But: The Redefining Intimacy Menu: a resource specifically designed for when intimacy needs to be redefined beyond penetration and intercourse.
Related Posts:
